.svg){kind=small}
It's been a long journey since the 1980s, when we first started engaging patients in clinical research and development. Patient engagement (PE) is a process that brings together patients, patient advocates, patient representatives, and/or caregivers in a collaborative effort to make an impact on the drug development lifecycle.
It's a chance for all stakeholders to come together and make a difference. In this blog, we'll explore the impact of patient engagement (PE) and discover how to make it happen in your organization.
The Value of Patient Engagement
There are so many benefits that patient engagement offers to clinical development.
Understanding unmet needs
Patients can provide invaluable insights into their experiences with their conditions and the limitations of existing treatments. This can help researchers identify unmet needs and develop more effective therapies, which is a win-win for everyone. For example, patients can help identify gaps in current clinical care and available therapies during the early discovery and preclinical phases—and they can do so in a way that benefits everyone involved.
People living with Huntington's disease and their families worked closely with researchers to identify the most pressing unmet needs in their care and demand solutions. They made it clear that treatments that address both motor and cognitive symptoms, as well as the emotional and psychiatric aspects of the disease, are essential. Through collaborative discussions, people with HD helped researchers prioritize which aspects of the disease to focus on in the early stages of drug discovery. This led to a shift in focus from solely targeting motor symptoms to also considering cognitive decline and psychiatric issues.
Finally, people with HD contributed to the development of a Target Value Profile (TVP) for potential HD treatments. This helped researchers understand what outcomes would be most meaningful to patients, such as maintaining independence and quality of life, rather than just focusing on clinical measures.
Setting Research Priorities
Patients help shape research priorities and ensure that studies focus on the issues that matter most to them by communicating their unmet treatment needs and desired outcomes.
Optimizing Clinical Trial Design
The great thing about patient input is that it can lead to more patient-focused study designs, which makes trials more relevant and accessible for participants. This can involve making some needed improvements to clinical trial protocols, including aspects like inclusion/exclusion criteria, endpoints, and study procedures to reduce the burden on participants.
Improving Patient Enrollment and Retention
When patients are actively involved in the research process, they are more likely to enroll in clinical trials and remain engaged throughout the study duration. Decentralized clinical trials (DCTs) can further enhance participation by reducing the logistical burden of on-site trial participation. A systematic review and meta-analysis published in the British Medical Journal (BMJ) investigated the impact of patient and public involvement on rates of enrolment and retention in clinical trials. The meta-analysis found that patient engagement interventions modestly but significantly increased the odds of participant enrolment in clinical trials.
Implementing Patient Engagement
To effectively implement PE at your company or organization, consider the following essentials:
Establish Clear Goals and Expectations
As a foundational activity, define the purpose and scope of patient involvement from the outset, ensuring all stakeholders are aligned on expectations. Many times in our work that means creating a short and basic charter for the activity so that everyone is clear on their role and the ground rules for working together.
Identify and Recruit Patient Partners
Next, it's time to identify and recruit some partners who have the lived experience with the disease or condition. Get out there and find the perfect people to join the project. Collaborate with patient organizations, advocacy groups, and online communities to find individuals with relevant experiences and expertise.
Provide Training and Support
We're pleased to provide training and support whenever it's needed. We're here to equip our patient partners with all the knowledge and skills they need to participate in the research process with confidence. This may involve providing education about clinical research, specific therapeutic areas, or the drug development process—and it's a great way to get people excited about the possibilities of new treatments.
Use Appropriate Methods
It's important to tailor the engagement approach to the specific stage of development and the type of input needed. This is an opportunity to make a real difference while building a relationship with patient experts. There are so many great ways to get input from patients. You can use patient advisory boards, focus groups, surveys, interviews, and other creative formats that meet the needs of your participants.
Foster Open Communication
We need to create a collaborative environment where people feel comfortable sharing their perspectives and concerns. It's so important to keep the lines of communication open and transparent throughout the process. Let's make sure we're giving our partners regular updates on how their input is being used.
Measure Impact
While with the fast pace of the industry, sometimes this part is forgotten, it's crucial to track the impact of PE initiatives on research outcomes, patient satisfaction, and organizational efficiency. This presents an opportunity to collect data on patient enrollment, retention rates, and the incorporation of patient feedback into study designs.
Overcoming Challenges in Patient Engagement
Implementing PE can present some challenges:
Lack of Universal Guidance
There's still room for improvement when it comes to universal guidance. The absence of a universally agreed code of practice for PE presents an exciting opportunity for us to define what PE should look like in practice. Fortunately, several organizations, including the FDA, CIOMS, EUPATI, and PFMD, have already taken the initiative to propose frameworks and guidance documents. However, there is still a great opportunity for further efforts to develop standardized practices.
Operationalizing Patient Engagement
Translating PE principles into concrete actions is an exciting challenge. Specific guidance is needed on practical aspects, such as how to collect and integrate patient input, determine the number and type of patients to engage, and ensure meaningful and sustained involvement.
Measuring and Demonstrating Value
Quantifying the return on investment for PE initiatives is an opportunity to showcase the impact of PE and may be needed to justify further resource allocation for PE in the future.
